Developing novel Lin28 inhibitors by computer aided drug design
Abstract Lin28 is a key regulator of cancer stem cell gene network that promotes therapy-resistant tumor progression in various tumors. However, no Lin28 inhibitor has been approved to treat cancer patients, urging exploration of novel compounds as candidates to be tested for clinical trials. In thi...
Saved in:
Main Authors: | , , , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Publishing Group
2025-01-01
|
Series: | Cell Death Discovery |
Online Access: | https://doi.org/10.1038/s41420-024-02281-z |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|